Latest Immudyne Inc (IMMD) Headlines ImmuDyne
Post# of 10
Posted On: 03/10/2014 6:17:32 AM
Latest Immudyne Inc (IMMD) Headlines
ImmuDyne Announces Patient Program in Association With Leading Physicians of the Stone Center
GlobeNewswire - Tue Feb 11, 8:15AM CST
ImmuDyne, Inc. (OTCQB:IMMD) announced today that it has established a partnership with leading physicians of the Stone Center of New Jersey for its new nutritional supplements; iNR Wellness and iNR Wellness MD.
ImmuDyne Opens New Online Store for Immune Health and Wellness, iNRStart.com
GlobeNewswire - Wed Jan 08, 8:00AM CST
IMMUDYNE, Inc. (OTCQB:IMMD) announced the opening of the Company's new online store, iNRStart.com (http://www.iNRStart.com), for the retail sale of its new naturally derived nutritional supplements; iNR Wellness(TM), iNR Wellness MD(TM), and iNR Strength(TM).
ImmuDyne to Form Strategic Joint Venture With European Investment Firm for Ex-US Product Launch
GlobeNewswire - Wed Dec 18, 8:00AM CST
ImmuDyne, Inc. (OTCQB:IMMD) (the "Company") and Adiuvo ("Adiuvo"), a life-science and healthcare investment company domiciled in Central Europe, today announced the signing of a Memorandum of Understanding (MOU) to form a strategic Joint Venture ("JV") on all non-US business to anticipate the filing of new patents.
ImmuDyne Announces Affiliate Partnership With Leading Men's Lifestyle Magazine for PFI(TM) Product, Launching This Fall
GlobeNewswire - Wed Jul 17, 8:30AM CDT
ImmuDyne, Inc. (OTCQB:IMMD) announced today that it has signed an affiliate partnership agreement with Kandy Magazine for the promotion of Primed For Immunity(TM) (PFI(TM)), the Company's proprietary hangover prevention product.
ImmuDyne (OTCQB: IMMD) Announces Investor Awareness Campaign, Anticipates Strong Growth
GlobeNewswire - Thu Jun 27, 8:15AM CDT
ImmuDyne, Inc. (OTCQB:IMMD) announced today that the Company is launching an investor awareness campaign beginning on July 9, 2013 and continuing throughout 2013. The Company will be implementing strategies and tactics designed to increase market awareness of ImmuDyne and its product portfolio, among strategic investors, institutions and analysts.
ImmuDyne Announces Primed For Immunity(TM) Release at Exclusive, Red Carpet Event in Hollywood, CA With Leading Men's Lifestyle Magazine
GlobeNewswire - Wed Jun 12, 8:30AM CDT
ImmuDyne, Inc. (OTCQB:IMMD) announced today that it will be releasing Primed For Immunity(TM) (PFI(TM)), the Company's proprietary peri-/post alcohol product, at an exclusive, red carpet event in Hollywood, CA with a leading men's lifestyle magazine.
ImmuDyne Announces 30% Growth in 6-Month Sales of Cosmetic and Anti-Aging Skin Care Ingredients
GlobeNewswire - Thu Jun 06, 8:44AM CDT
ImmuDyne, Inc. (OTCQB:IMMD) announced today that the company has recorded sales growth of 30% in the first 6 months of 2013, as compared to the same period in 2012, in its cosmetic and anti-aging skin care segments.
ImmuDyne to Launch Proprietary Dietary Supplement in the U.S. Alcohol Consumption and Hangover Markets
GlobeNewswire - Tue Jun 04, 8:30AM CDT
ImmuDyne, Inc. (OTCQB:IMMD) announced today that the company plans to launch a new, proprietary dietary supplement in the U.S. alcohol consumption and hangover markets later this year.
ImmuDyne Appoints Joseph V. DiTrolio, M.D. as U.S. Chief Medical Officer
GlobeNewswire - Wed May 29, 3:30AM CDT
ImmuDyne, Inc. (OTCQB:IMMD) announced today that the company has appointed Joseph V. DiTrolio, M.D. as the Chief Medical Officer, United States.
Immudyne Announces 15-Month Plan for Growth and April 25th Conference Call
GlobeNewswire - Thu Apr 18, 10:23AM CDT
Immudyne, Inc. (OTCQB:IMMD) announced today that the company plans to execute a 15-Month Sales and Marketing Plan to accomplish increased revenue growth. The company will hold a conference call on Thursday, April 25th at 11 a.m. EDT. To participate in the call, please dial 1-800-816-4164. When prompted, enter the GUEST CODE of 636174#
Immudyne Appoints Karen Kingston, Former Brand Strategist for Johnson & Johnson, Pfizer, and Allergan, to Lead Global Marketing and Sales
GlobeNewswire - Mon Mar 25, 9:42AM CDT
Immudyne, Inc. (OTCQB:IMMD) announced today that Karen Kingston has been appointed as the company's Chief Marketing Officer to lead its global sales and marketing efforts.
ImmuDyne Announces Patient Program in Association With Leading Physicians of the Stone Center
GlobeNewswire - Tue Feb 11, 8:15AM CST
ImmuDyne, Inc. (OTCQB:IMMD) announced today that it has established a partnership with leading physicians of the Stone Center of New Jersey for its new nutritional supplements; iNR Wellness and iNR Wellness MD.
ImmuDyne Opens New Online Store for Immune Health and Wellness, iNRStart.com
GlobeNewswire - Wed Jan 08, 8:00AM CST
IMMUDYNE, Inc. (OTCQB:IMMD) announced the opening of the Company's new online store, iNRStart.com (http://www.iNRStart.com), for the retail sale of its new naturally derived nutritional supplements; iNR Wellness(TM), iNR Wellness MD(TM), and iNR Strength(TM).
ImmuDyne to Form Strategic Joint Venture With European Investment Firm for Ex-US Product Launch
GlobeNewswire - Wed Dec 18, 8:00AM CST
ImmuDyne, Inc. (OTCQB:IMMD) (the "Company") and Adiuvo ("Adiuvo"), a life-science and healthcare investment company domiciled in Central Europe, today announced the signing of a Memorandum of Understanding (MOU) to form a strategic Joint Venture ("JV") on all non-US business to anticipate the filing of new patents.
ImmuDyne Announces Affiliate Partnership With Leading Men's Lifestyle Magazine for PFI(TM) Product, Launching This Fall
GlobeNewswire - Wed Jul 17, 8:30AM CDT
ImmuDyne, Inc. (OTCQB:IMMD) announced today that it has signed an affiliate partnership agreement with Kandy Magazine for the promotion of Primed For Immunity(TM) (PFI(TM)), the Company's proprietary hangover prevention product.
ImmuDyne (OTCQB: IMMD) Announces Investor Awareness Campaign, Anticipates Strong Growth
GlobeNewswire - Thu Jun 27, 8:15AM CDT
ImmuDyne, Inc. (OTCQB:IMMD) announced today that the Company is launching an investor awareness campaign beginning on July 9, 2013 and continuing throughout 2013. The Company will be implementing strategies and tactics designed to increase market awareness of ImmuDyne and its product portfolio, among strategic investors, institutions and analysts.
ImmuDyne Announces Primed For Immunity(TM) Release at Exclusive, Red Carpet Event in Hollywood, CA With Leading Men's Lifestyle Magazine
GlobeNewswire - Wed Jun 12, 8:30AM CDT
ImmuDyne, Inc. (OTCQB:IMMD) announced today that it will be releasing Primed For Immunity(TM) (PFI(TM)), the Company's proprietary peri-/post alcohol product, at an exclusive, red carpet event in Hollywood, CA with a leading men's lifestyle magazine.
ImmuDyne Announces 30% Growth in 6-Month Sales of Cosmetic and Anti-Aging Skin Care Ingredients
GlobeNewswire - Thu Jun 06, 8:44AM CDT
ImmuDyne, Inc. (OTCQB:IMMD) announced today that the company has recorded sales growth of 30% in the first 6 months of 2013, as compared to the same period in 2012, in its cosmetic and anti-aging skin care segments.
ImmuDyne to Launch Proprietary Dietary Supplement in the U.S. Alcohol Consumption and Hangover Markets
GlobeNewswire - Tue Jun 04, 8:30AM CDT
ImmuDyne, Inc. (OTCQB:IMMD) announced today that the company plans to launch a new, proprietary dietary supplement in the U.S. alcohol consumption and hangover markets later this year.
ImmuDyne Appoints Joseph V. DiTrolio, M.D. as U.S. Chief Medical Officer
GlobeNewswire - Wed May 29, 3:30AM CDT
ImmuDyne, Inc. (OTCQB:IMMD) announced today that the company has appointed Joseph V. DiTrolio, M.D. as the Chief Medical Officer, United States.
Immudyne Announces 15-Month Plan for Growth and April 25th Conference Call
GlobeNewswire - Thu Apr 18, 10:23AM CDT
Immudyne, Inc. (OTCQB:IMMD) announced today that the company plans to execute a 15-Month Sales and Marketing Plan to accomplish increased revenue growth. The company will hold a conference call on Thursday, April 25th at 11 a.m. EDT. To participate in the call, please dial 1-800-816-4164. When prompted, enter the GUEST CODE of 636174#
Immudyne Appoints Karen Kingston, Former Brand Strategist for Johnson & Johnson, Pfizer, and Allergan, to Lead Global Marketing and Sales
GlobeNewswire - Mon Mar 25, 9:42AM CDT
Immudyne, Inc. (OTCQB:IMMD) announced today that Karen Kingston has been appointed as the company's Chief Marketing Officer to lead its global sales and marketing efforts.
(0)
(0)